Related Experiment Video
Updated: Jan 2, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.2K
Innovative Diabetes Interventions in the U.S. Hispanic Population
Addie L Fortmann1, Kimberly L Savin2, Taylor L Clark2
1Scripps Whittier Diabetes Institute, Scripps Health, San Diego, CA.
Summary
Hispanics with type 2 diabetes need tailored interventions. Culturally adapted live and technology-based approaches show promise for improving health outcomes in this population.
Area of Science:
- Diabetes research
- Health disparities
- Intervention science
Background:
- Hispanics in the U.S. face a 66% higher risk of type 2 diabetes.
- This demographic experiences poorer health outcomes post-diagnosis compared to non-Hispanic whites.
Purpose of the Study:
- To review innovative, real-world interventions for type 2 diabetes in underserved Hispanics.
- To identify key components of successful live and technology-based approaches.
Main Methods:
- Selective review of evidence on behavioral, psychosocial, and clinical outcomes.
- Analysis of live and technology-based intervention strategies.
- Evaluation of cultural tailoring's impact.
Main Results:
- Successful live interventions featured multimodal delivery, higher attendance, and in-person components.
- Effective technology-based interventions utilized frequent, intermittent communication, bi-directional messaging, tailored feedback, and human interaction.
- Cultural tailoring enhanced outcomes across both modalities.
Conclusions:
- Culturally tailored, multimodal interventions are crucial for improving type 2 diabetes outcomes in Hispanic populations.
- Further research is needed to refine intervention components, duration, and address intra-group variability for sustainability.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
809
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
809
01:22Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
01:22Diabetes Mellitus: Overview and Type I Subtype
4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
543
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
543
01:06Oral Hypoglycemic Agents: Glinides
537
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
537